Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Can DIY Medicine Tame Rampaging Healthcare Costs?

Simon M. Helfgott, MD  |  Issue: April 2015  |  April 1, 2015

CVM/shutterstock.com
Image Credit: CVM/shutterstock.com
Some companies are coming up with innovative ways to save healthcare consumers money.

Three trillion dollars. That’s trillion with a t. That’s more money than the annual gross domestic product (GDP) of Canada and South Korea combined. At a rate of spending exceeding more than $8 billion a day, the U.S. healthcare system is a massive behemoth, guzzling and spewing 20% of the U.S. GDP. By comparison, the 2015 Pentagon budget, a paltry $0.8 trillion, is surpassed by healthcare expenditures annually before the end of April. There is no enterprise in the world that remotely approaches the size and scope of American medicine.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In his book, America’s Bitter Pill, the investigative reporter Steven Brill outlined the key drivers that make our healthcare at least 60% more costly than any other system anywhere: exorbitant hospital charges, spiraling costs of medication, relatively hefty provider fees, all capped by an eye-popping $0.4 trillion to cover administrative costs, the icing on a very rich cake.1

A lengthy procession of politicians and healthcare administrators has offered an array of remedies that were supposed to bend the rising slope of the healthcare spending curve, the most recent being The Affordable Care Act (ACA), better known as Obamacare. These efforts include cost shifting to patients (e.g., higher co-payments), tightening access to costly drugs (e.g., formulary exclusions) and pruning provider networks (e.g., excluding some providers, primarily for financial reasons). Many annual insurance deductibles now routinely exceed $5,000.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Some policy experts applaud the shift of the fiscal burden from insurer to patient, viewing this development as a healthy one. To follow this line of reasoning, forcing patients to become more price conscious alters their purchasing behaviors accordingly. However, one key ingredient is missing in this messy remedy: price transparency. Shouldn’t consumers be able to review a list of charges before they make their decisions? Isn’t that the way commerce normally works?

Overspending on healthcare creates some major heartburn for our economy. First, it chokes off the potential growth of other economic sectors because so much of GDP is consumed by healthcare. Although the annual growth rate has slowed, the total cost of healthcare remains so enormous that just a 3% rise in growth amounts to an additional $100 billion per year. Second, some medical bills are simply insurmountable and account for about 20% of all personal bankruptcies.

It may turn out that the steady shifting of costs to our patients’ wallets may provide the greatest impetus for disruption of the colossal healthcare apparatus. A growing number of patients have quietly moved to the newest frontier in healthcare, best described as do it yourself (DIY) care. DIY care is an effort to provide quality care at reasonable prices that are transparent, two concepts totally alien to the U.S. market. DIY care is teeming with some exciting ideas and not every one of them involves using a smartphone app! Imagine if some forms of DIY care were to gain a foothold in a $3 trillion industry. Their success could force traditional stakeholders to reexamine their costly, and often illogical, ways of doing business. Let’s explore a few of these new ideas.

Bloody Simple

To describe Elizabeth Holmes as an overachiever would be something of an understatement. Even among the high-flying whiz kids of Silicon Valley, her intellect and determination stand out.2 After completing her junior year at Stanford University in Palo Alto, Calif., she conceived a way to perform multiple laboratory tests at once, using the same drop of blood, and to wirelessly deliver the resulting information to a doctor. That summer, she filed a patent for the idea, one that was ultimately granted in November 2007.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:OpinionPractice SupportRheuminationsSpeak Out Rheum Tagged with:costsHealth InsuranceHelfgottMedicationprescription drugrheumatologysurgical procedure

Related Articles

    Technological Advances Linked to Medical Misadventures

    April 15, 2016

    For keen students of American politics, the unending intrigue of the 2016 presidential race has been riveting. With an assemblage of aspiring candidates that, at its start, included a bevy of U.S. senators and former governors, a media-savvy real estate mogul, a renowned Hopkins neurosurgeon and an ophthalmologist, political junkies among us have feasted on…

    Crowdsourcing: The Modern Consult Equivalent

    October 13, 2015

    Two of the great traditions of medicine are the curbside and party consults. In the former, participating physicians informally discuss an especially difficult diagnostic problem. During the latter, a patient will approach the doctor to ask about some possible medical problem and what they should do about it. The advent of the Internet has brought…

    Theranos Lab May Pose Jeopardy to Patient Health

    February 1, 2016

    (Reuters)—Deficient practices at a lab operated by blood-testing startup Theranos pose “immediate jeopardy to patient health and safety,” the U.S. government’s Centers for Medicare & Medicaid Services said in a letter to the company released on Wednesday. Theranos, founded and led by Elizabeth Holmes, has been in the spotlight after reports in the Wall Street…

    Corona Borealis Studio / shutterstock.com

    The Reliability & Utility of Serological Antibody Tests in COVID-19

    September 11, 2020

    Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies may play a critical role in the management of the worldwide health crisis. Such testing may reveal key information for epidemiology, convalescent plasma therapies and vaccine development. However, the situation is complex, and much is unknown. Although such testing may ultimately be used to…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences